Australia's implantable ports grow amidst rising cancer cases

There has been a growing need to control dosage of chemotherapy drugs.

A rising prevalence of cancer and availability of advanced treatment options contribute to the growth of Australia’s implantable ports market, which is expected to grow at a compound annual growth rate of 4% between 2020 and 2025, according to GlobalData.

“Technical advancements, increasing awareness of implantable ports, ease of use and patients’ choice to opt for effective treatment methodologies are driving the demand for implantable ports,” GlobalData’s medical devices analyst Minith Kumar said.

Improvement in technology and access to quality healthcare facilities are also expected to further boost the market growth. As physicians consider chemotherapy as the standard for cancer treatment, a growing need to control the dosage of drugs will drive the demand for implantable ports, Kumar said.

“Increasing focus on developing new implantable ports with advanced features for better delivery of medications will also contribute to the implantable ports markets growth in the future,” he added.

Single lumen ports accounted for more than 95% of the Australian market in 2020.